Print
Email
Print Edition Stories
MHT's Galen Moore: Mass. companies building to be sold
MHT's Julie Donnelly: Boston lines up tech events for fall calendar
Exogenesis Corp., a gas cluster ion beam (GCIB) technology firm in Billerica, has raised $3.19 million in an equity and securities offering filed Monday with the U.S. Securities and Exchange Commission. The offering is intended to reach $20 million, according to the regulatory filing.
The financing represents the second equity offering in the last six months. In June, Exogenesis submitted a regulatory filing for a $3.7 million offering, planned for $4.1 million. The filing was later amended in August to reflect the company’s raising of a $4.5 million equity offering.
The company’s investors, as listed on its website, include Inflection Point Ventures, Venture Capital Fund of New England and JDS Uniphase Corp., as well as individual backers.
Founded in 2005, Exogenesis uses the GCIB technology to process implantable medical devices, according to the Exogenesis website. The company has developed the ClusterCoat Processing System, used in surface coating medical devices by changing the physical and chemical properties of the atomic layers of a surface.
Exogenesis’ core technology, GCIB, was first developed in the 1990s at Kyoto University’s Ion Beam Engineering Experimental Laboratory, with further development conducted at Epion Corp. in the U.S.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
